Literature DB >> 29576469

Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways.

Bansari G Patel1, Emily E Lenk1, Dan I Lebovic2, Yimin Shu1, Jie Yu1, Robert N Taylor3.   

Abstract

Despite an estimated prevalence of 11% in women and plausible historical descriptions dating back to the 17th century, the etiology of endometriosis remains poorly understood. Classical theories of the histological origins of endometriosis are reviewed below. Clinical presentations are variable, and signs and symptoms do not correlate well with the extent of disease. In this summary, we have attempted to synthesize the growing evidence that hormonal and immune factors conspire to activate a local inflammatory microenvironment that encourages endometriosis to persist and elaborate mediators of its two cardinal symptoms: pain and infertility. Surprisingly, in the search for novel therapeutics for medical treatment of endometriosis, some compounds appear to have dual pharmacological functions, simultaneously modifying the endocrine and immune system facets of this complex gynecologic syndrome. We predict that these lead drugs will provide more therapeutic choices for patients in the future.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Endometriosis; Estrogen; GnRH (gonadotropin-releasing hormone); Progesterone; SERM (selective estrogen receptor modulator)

Mesh:

Year:  2018        PMID: 29576469     DOI: 10.1016/j.bpobgyn.2018.01.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  35 in total

Review 1.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

Review 2.  Environmental Endocrine Disruptors and Endometriosis.

Authors:  Jelonia T Rumph; Victoria R Stephens; Anthony E Archibong; Kevin G Osteen; Kaylon L Bruner-Tran
Journal:  Adv Anat Embryol Cell Biol       Date:  2020       Impact factor: 1.231

3.  Exosomal tRF-Leu-AAG-001 derived from mast cell as a potential non-invasive diagnostic biomarker for endometriosis.

Authors:  Yingxue Li; Shuling Cui; Zemin Xu; Yanping Zhang; Tao Wu; Jing Zhang; Yichen Chen
Journal:  BMC Womens Health       Date:  2022-06-25       Impact factor: 2.742

4.  SCM-198 Prevents Endometriosis by Reversing Low Autophagy of Endometrial Stromal Cell via Balancing ERα and PR Signals.

Authors:  Yi-Kong Lin; Yun-Yun Li; Yue Li; Da-Jin Li; Xiao-Lin Wang; Li Wang; Min Yu; Yi-Zhun Zhu; Jia-Jing Cheng; Mei-Rong Du
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

Review 5.  The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.

Authors:  Jan Korbecki; Iwona Szatkowska; Patrycja Kupnicka; Wojciech Żwierełło; Katarzyna Barczak; Iwona Poziomkowska-Gęsicka; Jerzy Wójcik; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 6.  An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.

Authors:  Ivan Urits; Leena Adamian; Paulo Miro; Jessica Callan; Parth M Patel; Megha Patel; Amnon A Berger; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

Review 7.  Endometriosis and in vitro fertilisation.

Authors:  Loukia Vassilopoulou; Michail Matalliotakis; Maria I Zervou; Charoula Matalliotaki; Demetrios A Spandidos; Ioannis Matalliotakis; George N Goulielmos
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

8.  Endometriosis on the surface of the uterus mimicking a malignant tumor: A case report with literature review.

Authors:  Lihong Pang; Honghui Shi; Tao Wang; Lan Zhu; Jinghe Lang; Qingbo Fan; Haiyuan Liu; Xin Yu; Yang Cao; Yu Xiao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 9.  Complementary and Alternative Medicine for Dysmenorrhea Caused by Endometriosis: A Review of Utilization and Mechanism.

Authors:  Ying Guo; Fang-Yuan Liu; Ying Shen; Jia-Yue Xu; Liang-Zhen Xie; Shi-Ying Li; Dan-Ni Ding; Dan-Qi Zhang; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

10.  Identification and Exploration of Novel Macrophage M2-Related Biomarkers and Potential Therapeutic Agents in Endometriosis.

Authors:  Zhongqi Cui; Ramesh Bhandari; Qin Lei; Mingzhi Lu; Lei Zhang; Mengmei Zhang; Fenyong Sun; Lijin Feng; Shasha Zhao
Journal:  Front Mol Biosci       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.